::  C. Van Morris M.D.

Education:

• Medical College of Georgia 1972
• University of NC Memorial Hospital Internship - Graduated 1973
• University of NC Memorial Hospital Department of Medicine, residency completed 1975
• North Carolina Memorial Department of Neurology, residency completed 1978

• American Academy of Neurology - Board Certified

::  H. McCord Smith M.D.

Education:

• 1964 - 1967 Presbyterian College, Clinton, South Carolina, B.A. 1976 Summa Cum Laude
• 1967 - 1968 Emory University, Atlanta, Georgia
• 1968 - 1974 Emory University School of Medicine, Atlanta, Georgia, M.D. 1974

• 1974 - 1975 Rotating Pediatric/Medicine Internship, Grady Memorial Hospital, Atlanta, VA Hospital, Atlanta Georgia
• 1975 - 1977 Assistant Resident, Neurology, North Carolina Memorial Hospital, Chapel Hill, North Carolina
• 1977 - 1978 Chief Resident, Neurology, North Carolina Memorial Hospital, Chapel Hill, North Carolina

• Athens Neurological Associates, P.C., Athens, Georgia - 1978 to present
• Director Stroke Project and Rehabilitative Medicine, St. Mary's Hospital, Athens, Georgia - 2001 to present
• President Medical Staff, St. Mary's Hospital, Athens, Georgia - 2003

• National Board of Medical Examiners, 1975
• American Board of Psychiatry and Neurology, 1980

• North Carolina, 1975
• Georgia, 1978

• American Academy of Neurology, 1975; Fellow 1987
• America EEG Society, 1982
• Georgia Neurological Society, 1978
• Crawford Long Medical Society, 1978

• Smith, HM, Basmjian, JV, Vanderstoep, SF: Inhibition of neighboring motoneurons in conscious control of single spinal motoneurons Science 183: 975-976, 1974

• University of Georgia School of Pharmacy, part time lecturer, 1978 - 1994

::  Edward S. Novey M.D.

Educational Background:

• 1964 - 1968 Leon High School, Tallahassee, Florida
• 1968 - 1969 Emory University, Atlanta, Georgia
• 1969 - 1972, Florida State University, B.S. Biology Tallahassee, Florida
• 1972 -1976, University of Miami, M.D. Miami, Florida
• 1976 - 1977, University of Florida Department of Medicine, Medical Internship, Gainesville, Florida
• 1977 - 1980, University of Florida Department of Medicine, Department of Medicine, Resident, Gainesville, Florida

• Pierian Honor Society - Leon High School, 1968
• Psychiatry Achievement Award - University of Miami Medical School, 1976
• Secretary Medical Staff - St. Mary's Hospital, 1983
• Secretary Medical Staff - Athens Regional Medical Center, 1984
• President Elect Medical Staff - Athens Regional Medical Center, 1985
• President Medical Staff - Athens Regional Medical Center, 1986
• Medical Director - St. Mary's Hospital Rehabilitation Service, 1984 - 1994
• Medical Director - Athens Magnetic Imaging, 1987 - 2000
• Medical Director - EEG Lab, Athens Regional Medical Center, 1984 - 1994
• Medical Director - EEG Lab, St. Mary's Hospital 1984 - 1994

• "Dyslexia and Corpus Callosum Morphology",George W. Hynd, Josh Hall, Edward S. Novey,Deborah Eliopulos, Kathryn Black, Jose J. Conzales, Jane E. Edmonds, Cynthia Riccio, Morris Cohen, Archives of Neurology, Vol. 52, pp. 32-38
• "Attention Deficit - Hyperactivity Disorder and Asymmetry of the Caudate Nucleus" George W. Hynd, Kelly L. Hem, Edward S. Novey, Deborah Eliopulos, Richard Marshall, Jose J. Gonzales, Kytja K. Voeller, Journal of Child Neurology, Vol. 8, October 1993, pp. 339, 347
• "Brain Morphology in Developmental Dyslexia and Attention Deficit Disorder/Hyperactivity", G. W. Hynd, M. Semrud-Clikeman, A. R. Lorys, E. S. Novey, Deborah Eliopulos, Archives of Neurology, Vol. 47, pp. 919-926

• American Academy of Neurology - Board Certified November 1982, #24392
• Crawford Long Medical Society
• Medical Association of Georgia

• State of Florida (inactive)
• National Board of Medical Examiners
• State of Georgia #21265 - 2/13/80

• Emory University, 10/25/85, Neuroradiology Update - MRI (CME 5.5 hours)
• American Academy of Neurology, 04/27/86, Neuroimaging - MRI (CME 6.5 hours)
• Emory University, 10-23-87, Magnetic Resonance Imaging (CME 30 hours)
• Georgia Baptist Medical Center, 03/02/95, Current Clinical Indications for MRI (CME 1 hour)
• American Society of Neuroimaging, 03/09-11/95, MRI/CT Course (CME 9 hours), Advanced MRI (CME 4 hours), Vascular Disease of the Nervous System (CME 3 hours)
• Georgia Baptist Medical Center, 04/08/95, Current Clinical Indications for MRI (CME 1 hour)
• 13 years experience as Medical Director of Athens Magnetic Imaging involving the Clinical Directorship of the Imaging Center and interpretation on a daily basis of Magnetic Resonance Imaging of the nervous system.

::  James A. Elmore M.D.

Education:

• Medical University of SC, Graduated 1983 Charleston, SC
• Eastern Virginia Graduate, Internship - Completed 1983 School Norfolk, VA
• Medical College of GA, Neurology Residency - Completed 1984 Augusta, GA

• American Academy of Neurology
• Medical Association of Georgia

• Diplomate of American Board of Psychiatry and Neurology - April 1994, #39463
• Diplomate of National Board of Medical Examiners, July 1984, State of Georgia. #27454

• Saint Mary's Hospital, 1230 Baxter Street, Athens, Georgia 30606
• Athens Regional Medical Center, 1199 Prince Avenue, Athens, Georgia 30606

::  Terry L Wimpey M.D. Ph.D.

Licensure:

• Medical Board of California
• Medical Board of Georgia

• American Board of Psychiatry and Neurology (Diplomate since 12/01)
• American Board of Sleep Medicine (Diplomate since 4/03)
• ABPN Certification in the Subspecialty of Clinical Neurophysiology (2001)
• American Clinical Neurophysiology Society Exam (Board Eligible)

• B.A., Emory University Department of Chemistry, Atlanta, Georgia 1980-1983, Degree Conferred June, 1983
• Ph.D., University of Washington, School of Medicine Department of Pharmacology, Seattle, Washington 1986-1991, Degree Conferred June, 1991
• M.D., Emory University School of Medicine, Atlanta, Georgia 1991-1995, Degree Conferred (Cum Laude) May, 1995
• Resident in Neurology, University of California, San Francisco Department of Neurology, San Francisco, California 1995-1999
• Fellow in Clinical Neurophysiology/Sleep Medicine, Duke University, Durham, North Carolina 1999-2001

• U of WA Pharmacological Sciences Training Grant, 1989-1991
• EUSM Medical Student Research Fellowship, Summer 1992 and 1993
• Emory's 1995 Outstanding Student in Neurology
• Alpha Omega Alpha National Honor Medical Society

• Research technician: Georgia Institute of Technology, Department of Chemistry 1984-1986
• Teaching assistant: General Chemistry Labs, Georgia Institute of Technology 1985-1986
• Teaching assistant: General Pharmacology, University of Washington 1987-1988

• American Academy of Sleep Medicine
• American Academy of Neurology

• Medical School Research Project
  Sponsors: Steven Hersch, M.D., Ph.D. and Allan Levey, M.D., Ph. D. Department of Neurology
  Emory University (Summer 1991 and 1992)
  
  "Comparison of the expression of glutamate receptor subunits in control and Huntington's Disease brains."

• Doctoral Research Advisor: Charles Chavkin, Ph.D.
  Department of Pharmacology
  University of Washington (1986-1991)
  
  "Opioid Tolerance and Opioid Regulation of Potassium Conductances in Hippocampus" Doctoral Dissertation

• Gutekunst, C.A., Hersch, S.M., Wimpey, T., Yarlgdda, S., Blackstone, C., Huganir, R., and Levey, A.I. (1993). Western blot analysis of glutamate receptor subunits in Huntington's Disease. Soc. For Neurosci. Abst 19:410.

• Wimpey, T.L. and Chavkin, C. (1992). 8-Bromo-cAMP blocks opioid activation of a voltage-gated potassium current in isolated hippocampal neurons. Neurosci. Lett. 137: 137-140.

• Drake, C., Mulligan, K., Wimpey, T.L., Hendrickson, A. and Chavkin, C. (1991). Characteriztion of Vicia villosa agglutinin-labeled GABergic interneurons in the hippocampal formation and in acutely dissociated hippocampus. Brian Res. 554: 176-185.

• Wimpey, T. L. and Chavkin, C. (1991). Opioids activate both an inward rectifier and a novel voltage-gated potassium conductances in the hippocampal formation. Neuron 6: 281-289.

• Wimpey, T. L., Caudle, R.M. and Cavkin, C. (1990). Chronic morphine exposure blocks opioid effects on both the early and late inhibitory post synaptic potentials in hippocampal CA1 pyramidal cells. Neurosci. Lett. 110: 349-355.

• Wimpey, T.L., Opheim, K.E. and Chavkin, C. (1989). Effects of chronic morphine administration on the mu and delta opioid responses in the CA1 Region of the rat hippocampus. J. Pharmacol. Exp. Ther. 251: 405-411.

::  Jon Poling M.D. Ph.D.

Current Employment:

• Partner, Athens Neurological Associates (ANA) 2001-present
• Medical Director, Athens Regional Medical Center Apheresis Unit 2002-present

• Certified in MRI/CT interpretation, American Society of Neuroimaging 2006-present
• Diplomate, American Association of Neuromuscular and Electrodiagnostic Medicine 2004-present
• Board Certified, American Board of Psychiatry and Neurology 2002-present
• Georgia License #050051 2001-present
• Maryland License #D00560401 (inactive status) 2000-2001

• Johns Hopkins University, Department of Neurology/Neurosurgery, Neurology Resident 2001
• INOVA Fairfax Hospital/Georgetown Hospital, Transitional Intern 1998
• Georgetown University School of Medicine, Washington, DC - M.D./Ph.D. 1997
• Woods Hole Marine Biological Laboratory, Woods Hole - MA, Neurobiology Course Summer 1995
• Boston University, Boston, MA - B.A. with Honors, Biology 1991 (cum undergrad GPA- 3.90) 1991

• American Society of Neuroimaging 2004-present
• American Society for Apheresis 2002-present
• American Association of Neuromuscular and Electrodiagnostic Medicine 2001-present
• American Academy of Neurology 1998-present
• American Physiological Society 1996-1998
• Society for Experimental Biology and Medicine 1995-1998
• Society for Neuroscience 1994-1997
• American Medical Association 1991-1995

• NIH/NINDS Scholarship for Woods Hole Marine Biological Laboratory summer course in Neurobiology 1995
• Pre-doctoral Intramural Research Training Award (IRTA), NIH/NIAAA 1993-1996
• Medical Scientist Training Award, Georgetown University Full tuition scholarship (MD & PhD) 1991-1997
• Ruggles Scholarship, Georgetown University 1991-1993
• Alpha Epsilon Delta, Boston Univ. 1989
• Dean's List Boston University 1989-91
• Eagle Scout 1988

• Doctoral thesis study under the co-mentorship of Dr. Stefano Vicini at Georgetown Medical School, and Dr. Norman Salem, Jr. at the National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, Bethesda MD. (Committee Members: Dr. Michael A. Rogawski, Dr. Norman Hershkowitz, Dr. Toshio Kitazawa, Dr. Norman Salem, Jr., and Dr. Stefano Vicini) 1993-1996
• Summer research fellowship in the laboratory of Dr. John Karanian, Ph.D. at the National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, Laboratory of Clinical Studies, Bethesda MD 1989-1993
• Senior research dissertation for B.A. with distinction under Dr. Christine Li, Ph.D., Boston University, Department of Biology studying neuropeptides in C. elegans. 1990-1991

• Frye, R.E., Poling, J.S., Ma, L.C.K. (2006) Choroid Plexus Papilloma Expansion Over 7 Years in Aicardi Syndrome. Journal of Child Neurology, in press.
• Frye, R.E. and Poling J.S. (2006) Reversible posterior leukoencephalopathy syndrome (RPLS) in a patient with sickle cell anemia after blood transfusion. J Pediatric Hematology/Oncology, submitted.
• Poling J.S., Frye R.E., Shoffner J, Zimmerman A.W. (2006) Developmental Regression and Mitochondrial Dysfunction in a Child with Autism. Journal of Child Neurology 21 (2).
• Poling J.S., Aldrich E. Clinical Cases from Johns Hopkins Neurology: Hemorrhagic Mass Presenting as Seizure. November 2000. Medscape http://www.medscape.com/viewarticle/430118.
• Poling J.S., Rogawski M.A., N. Salem Jr., and Vicini S. (1997) Anandamide, an Endogenous Cannabinoid, Inhibits Shaker-related Voltage-Gated K+ Channels. Neuropharmacology 35 (11).
• Poling J.S., Vicini S., Rogawski M.A., and N. Salem, Jr. (1997) Docosahexaenoic Acid Block of Neuronal Voltage-Gated K+ Channels: Subunit Selective Antagonism by Zinc. Neuropharmacology 35 (11).
• Poling J.S., Karanian J.W., Vicini S., and N. Salem Jr. (1995) Time- and Voltage- Dependent Block of Delayed Rectifier Potassium Channels by Docosahexaenoic Acid. Molecular Pharmacology 47, 381-390.
• Horvath I., Poling J.S., and J.W. Karanian. (1996) Modulation of Thromboxane Induced Changes in Cerebral Blood Flow by Hydroxylated 22 Carbon Fatty Acids. Journal of Cerebral Blood Flow.
• Ph.D. DISSERTATION Poling J.S. (1995) On the Mechanism of Potassium Channel Blockade by Polyunsatured Fatty Acids and Cannabinoids. Doctoral Dissertation presented to Georgetown University Graduate School of Arts and Sciences on December 20, 1995.
• SENIOR THESIS FOR B.A. WITH DISTINCTION Poling J.S. (1991) Localization of the Neuropeptide FRMF-amide by Immunofluorescence in Mutants of C. elegans. Senior Research Thesis, Boston University.
• MEETING PRESENTATIONS (partial listing) Poling J.S. (2006) Vascular Dissections and Chiropractic Manipulation: "A Twist of Fate." St. Mary's Hospital Grand Rounds, Nov 15, 2006, Athens GA.
• Poling J.S. (2005) Wernicke's Encephalopathy as a Complication of Bariatric Surgery. St. Mary's Hospital Grand Rounds, Nov 2, 2005, Athens GA.
• Poling J.S., Rogawski M.A., Vicini S., and N. Salem Jr. (1995) Zinc Modulates Extracellular Fatty Acid Block of Recombinant Voltage-Gated Potassium Channels Expressed in Mammalian Cells. Soc for Neurosci Abstr 21, 1833.
• Vicini S, Wang J.F., Poling J.S., and D. Grayson. (1995) Functional and Pharmacological Differences Between Recombinant and Native NMDA Receptors. Soc for Neurosci Abstr 21, 86.
• Poling J.S., Rogawski M.A., Vicini S., and N. Salem Jr. (1995) Anandamide, the Putative Endogenous Cannabinoid, is an Open-Channel Blocker of Recombinant Potassium Channels in CL1023 Fibroblasts Stably Transfected with Kv1.2 cDNA. Society for Experimental Biology and Medicine 209, 299-302.
• Poling J.S., Vicini S., Rogawski M.A., and N. Salem, Jr. (1995) Blockade of Native and Recombinant Neuronal Voltage-Gated K+ Channels by Nanomolar Concentrations of Docosahexaenoic Acid: Structure-Activity Relationships and Antagonism by Zinc. Proceedings of the 2nd Congress of the International Society for the Study of Fatty Acids and Lipids.
• Frye R.E., Poling J.S. and S. Vicini (1994) Noise Fluctuation Analysis of Pineal Delayed Rectifier Channels and Modification by the Blocker, Docosahexaenoic Acid. Soc. Neurosci. Abstract 20, 1525.
• Poling J.S., N. Salem Jr. and S. Vicini. (1994) Docosahexaenoic Acid, the Major Polyunsaturate Found in Neuronal Membranes, is an Open-Channel Blocker of Voltage-Gated Potassium Channels. Soc. Neurosci. Abstract 20, 722.
• Karanian J.W., Poling J.S., and N. Salem Jr. (1992) Nutritional Regulation of Platelet and Vascular Smooth Muscle Function: Role of Hydroxylated Lipoxygenase Derivatives. Proceedings of the 5th Society on Polyunsaturated Fatty Acids.

::  Martha Trieschmann M.D.

Positions and Certifications:

• 2003-present: Physician, Athens Neurological Associates
• 2003-present: Board certified in Neurology, American Board of Psychiatry and Neurology

• Fellowship in Movement Disorders, Brown University, 2002-2003 Memorial Hospital of Rhode Island, Pawtucket, RI
• Fellowship in Electrophysiology/Neuromuscular Disease, Brown University, 2001-2002 Rhode Island Hospital, Providence, RI
• Residency in Neurology, Brown University 1998-2001 Rhode Island Hospital, Providence, RI
• Internship in Internal Medicine, Medical College of Georgia, 1997-1998 Augusta, GA
• Doctor of Medicine, Medical College of Georgia, 1993-1997 Augusta, GA
• Bachelor of Arts, Vanderbilt University, 1989-1993
  Magna cum laude, Honors in the College of Arts and Sciences
  Major: English, Minor: Chemistry
  Nashville, TN
  

• "Honorable Mention" for presentation on: Long Term Outcome of Quetiapine for Drug-Induced Psychosis among Parkinsonian Patients by Fernandez HH (presenting author), Trieschmann ME, Burke MA, Jacques C and Friedman JH. Presented at the XIV International Congress on Parkinson's Disease, Helsinki, Finland, July 28-31, 2001. >
• American Academy of Neurology Annual Meeting Scholarship, 2000
• Price Campbell Merit Scholarship (merit based for four years of medical education)
• Phi Beta Kappa
• Harold Stirling Vanderbilt Scholarship (merit based, full tuition for four years of undergraduate study)

• 2003-Present: St. Mary's Hospital, Athens, GA
• 2003-Present: Athens Regional Hospital, Athens, GA

• American Academy of Neurology
• Movement Disorders Society

• 2001-2003: Clinical Instructor, Department of Clinical Neurosciences Brown University School of Medicine
• July 2000-June 2001: Chief Resident, Department of Neurology, BrownUniversity/Rhode Island Hospital

• Friedman JH, Trieschmann ME, Myers RH, Fernandez HH. Monozygotic twins discordant for Huntington's disease after seven years. Archives of Neurology 2005; 62: 995-997.
• Ravina B, Putt M, Siderowf A, Farrar JT, Gillespie M, Crawley A, Fernandez HH, Trieschmann ME, Reichwein S, Simuni T. Donepezil for Dementia in Parkinson's disease: A randomized, double-blind, placebo-controlled, crossover study. J Neurol Neurosurg Psychiatry 2005 Jul;76(7):934-9.
• Fernandez HH, Trieschmann ME, Okun MS. Rebound Psychosis: Effect of Discontinuation of Antipsychotics in Parkinson's Disease. Movement Disorders 2005 Jan; 20(1):104-5.
• Fernandez HH, Trieschmann ME, and Friedman JH. Aripiprazole for drug induced psychosis in Parkinson's disease: preliminary experience. Clinical Neuropharmacology 2004; 27:4-5.
• Fernandez HH, Lannon MC, Trieschmann ME, Friedman JH. Botulinum Toxin Type B for Gait Freezing in Parkinson's Disease. Med Sci Monit 2004; 10 (7): 284-6.
• Friedman JH, Fernandez HH and Trieschmann ME. Parkinsonism in a Nursing Home: Under Recognition. Journal of Geriatric Psychiatry and Neurology 2004; 17: 39-41.
• Fernandez HH, Trieschmann ME, Burke MA, Jacques C, Friedman JH. Long-Term Quetiapine Use for Drug-Induced Psychosis Among Parkinsonian Patients. Mov Disord 2003; 18(5):510-4.
• Fernandez HH, Trieschmann ME, Friedman JH. The Treatment of Psychosis in Parkinson's Disease: Safety Considerations. Drug Safety 2003; 26 (9): 643-659.
• Fernandez HH, Trieschmann ME, Burke MA, Friedman JH. Quetiapine Use for Psychosis in Parkinson Disease versus Dementia with Lewy bodies. Journal of Clinical Psychiatry 2002; 63(6): 513-5
• Trieschmann, M, Gilchrist G. POEMS syndrome in a patient presenting with Chronic Inflammatory Demyelinating Polyneuropathy. Rhode Island Medical Journal 2002; 85(8):252-254.
• Cunanan M., Trieschmann, M. "Watershed Infarct: A Classic Presentation" Rhode Island Medical Journal, April 2001
• Trieschmann, ME, Fernandez HH, Friedman JH. New-Onset Diabetes in Parkinsonian Patients on Long-Term Quetiapine. Submitted to Clinical Neuropharmacology.

• Friedman JH, Trieschmann ME, Fernandez HH. Chapter 6: Drug-Induced Parkinsonism. In: Lang AE and Factor SA, eds. Drug-Induced Movement Disorders, 2nd edition. Futura Publishing, 2004: 105-142.
• Trieschmann M, Wilterdink J. Anticoagulant therapy and antiplatelet drugs. In: Noseworthy JH, ed. Neurologic Therapeutics, Principles and Practices, Martin Dunitz Publishers, London 2001.

• McCown K, Romrell J, Trieschmann ME, Friedman JH, Okun MS, Fernandez HH. New Onset Diabetes in Parkinsonian Patients on long-term quetiapine. Movement Disorders 2005; 20 (suppl 10): p 45.
• Ravina B, Putt M, Siderowf A, Farrar JT, Gillespie M, Crawley A, Fernandez HH, Trieschmann ME, Reichweing S, Simuni T. Donepezil for Dementia in Parkinson's Disease: A Randomized, Double-Blind, Placebo-Controlled Crossover Study. Movement Disorders 2004; 19: 1132.
• Trieschmann ME, Friedman JH, Myers RH, Fernandez HH. Monozygotic Twins Discordant for Huntington's disease after seven years. Movement Disorders 2004; 19 (suppl 9): s48.
• Fernandez HH, Trieschman ME, Friedman JH. Aripiprazole for drug-induced psychosis in Parkinson's disease: Preliminary experience. Movement Disorders 2004; 19 (suppl 9): s400.
• Fernandez HH, Trieschmann ME, Okun MS. Discontinuation of antipsychotic drugs in stable Parkinson Patients with a history of drug-induced psychosis. Movement Disorders 2004; 19 (suppl 9): s400.
• Fernandez HH, Friedman JH, Trieschmann ME. Parkinsonism in the Nursing Home. New York: American Psychiatry Association, 2004: 1623
• Fernandez HH, Lannon MC, Trieschmann ME, Friedman JH. Botulinum Toxin Type B for Gait Freezing in Parkinson's Disease. Movement Disorders 2003; 18: 1090.
• Trieschmann ME, Fernandez HH, Friedman JH. New-onset Diabetes in Parkinsonian patients on Long-Term Quetiapine. Movement Disorders 2003; 18: 1095.
• Trieschmann ME, Fernandez HH. Botulinum Toxin A for the Treatment of Painful Legs Moving Toes Syndrome. Movement Disorders 2003; 18: 1094.
• Fernandez HH, Trieschmann M, Burke M, Jacques C, Friedman JH. Long Term Outcome of Quetiapine for Psychosis Among Parkinsonian Patients. American Journal Geriatric Psychiatry 2002; 10(1): 98.
• Fernandez HH, Trieschmann M, Burke M, C. Jacques, Friedman JH. Long-Term Outcome of Quetiapine Use for Psychosis: Parkinson's Disease versus Dementia with Lewy Bodies. Movement Disorders 2001; 16 (Suppl 1): 32.
• Fernandez HH, Trieschmann M, Burke M, C. Jacques, Friedman JH. Long Term Outcome of Quetiapine for Drug-Induced Psychosis Among Parkinsonian Patients. Parkinsonism and Related Disorders 2001; 7 (suppl 1): 56.
• Fernandez HH, Trieschmann M, Burke M, Jacques C, Friedman JH. Drug-Induced Psychosis in Parkinsonian Syndromes: Predictors of Quetiapine Non-Response. Movement Disorders 2001; 16(5): 9.

::  Brian W. Mitchell M.D.

Education:

• 2003- 2006 Medical College of Georgia; Resident, Neurology
• 2002-2003 Medical College of Georgia, Internship, Internal Medicine
• 1998-2002 Medical College of Georgia,; M.D. GPA 4.0
• 1996-1998 University of Georgia/Medical College of Georgia PharmD, Pharmacy, GPA 4.0

• 2005/2006 Chief Resident in Neurology Medical College of Georgia
• 2003 Team member of Georgia ACP Medical Jeopardy Champions
• 2002 Outstanding Student in Neurology, Class of 2002
• 2002 Merck Manual Award 2002
• 2001 Alpha Omega Alpha Medical Honor Society (as a JMS)
• 2001 Regents Scholarship
• 2001 Ty Cobb Scholarship
• 1999 American Medical Association Scholarship
• 1998 Lilly Achievement Award for Academic Excellence (highest GPA in PharmD class)

• Advanced Cardiac Life Support, 07/2002
• Licensed as Physician and Pharmacist in Georgia

• 1996-2000 Part-time Pharmacist (Inpatient Pharmacy-DDEAMC, Fort Gordon, GA)

• 2001 Student Interest Group in Neurology, President, MCG chapter
• 2001-2005 American Academy of Neurology
• 2000-2005 Christian Medical & Dental Society

::  Eric M. Pitts M.D.

Education

• 8/1998-5/ 2002 - University of Nebraska Medical Center; Omaha, NE; M.D.
• 8/1994-5/1998 - Benedictine College; Atchison, KS; B.A. in biology (Magna Cum Laude). Minor in chemistry.

• 6/2002-6/2003 - Internship, Internal Medicine, Wake Forest University Baptist Medical Center, Winston-Salem, NC
• 7/2003-6/2006 - Residency in Neurology, Wake Forest University Baptist Medical Center, Winston-Salem, NC
• 7/2006-6/2007 - Neurophysiology Fellowship with Emphasis on Electromyography, Wake Forest University Baptist Medical Center, Winston-Salem, NC

• 2002 - Iota Benefit/Dr. William Angle Memorial Scholarship Award
• 2001 - College of Medicine Alumni Association Scholarship
• 2000 - Rudolph Lievers Scholarship
• 1999 - Margaret R. Noel Scholarship
• 1998 - Dr. Arch S. & Leone McMillen Scholarship
• 1998 - Magna cum Laude Graduate of Benedictine College
• 1994-1998 - Dean's Scholarship

• 2005-present - American Academy of Neurology
• 1998-present - American Medical Association
• 1998-2002 - American Medical Student Association

• 7/2004-6/2006 - Clinical Operations Committee

• 8/2001-5/2002 - Research project using transcranial magnetic stimulation to investigate the electrophysiology of multiple sclerosis. Principle investigator Dr. Eliad Culcea.

::  Holly Philpot MN, APRN-BC
    Clinical Nurse Manager

Holly Philpot joined ANA in 2003 as our first Nurse Practitioner. She is originally from Augusta, Georgia and completed both her Bachelor's and Master's degrees at the Medical College of Georgia. Working primarily with Drs Novey and Poling, she provides initial evaluation and ongoing treatment for patients with general neurological disorders.

• Advanced Practice Registered Nurse License (APRN), State of Georgia
• ANCC Board Certified Family Nurse Practitioner, originated August 2003
• Healthcare Provider CPR - current

• Master of Nursing - Family Nurse Practitioner, Summa Cum Laude, 4.0 GPA Medical College of Georgia, SONAT Athens, Georgia May 2003
• Bachelor of Science in Nursing, Cum Laude
  Medical College of Georgia
  Augusta, Georgia
  May 1996
  
• Pre-Nursing Core Curriculum
  University of Georgia, Honors Program
  Athens, Georgia
  August 1992 - May 1994

• Athens Neurological Associates
  Nurse Practitioner September 2003 - present
  Clinical Nurse Manager for ANA April 2006 - present
• Athens Regional Medical Center January 2000 - September 2003
  Emergency Department
  Charge Nurse
  Registered Nurse
  Preceptor for nursing students and new graduates.
• Medical College of Georgia Hospital July 1996 - November 1999
  Emergency Department and Level I Trauma Center
  Registered Nurse
  Preceptor for nursing students, medical students, and new nursing graduates.

• Georgia Nurses Association (Convention Delegate and Programs Chair 2003, Director 2004-2005)
• Northeast Georgia APRN Association (Vice President 2006-2007, Public Relations Director 2005)
• Federal Disaster Medical Assistance Team RN (DMAT-RN), Georgia-3, 1998-2003

• Georgia Nurses' Association District Honoree, 2005
• Nurse Practitioner Student of the Year, 2003, Medical College of Georgia
• Rebecca Andrews Scholarship Award Recipient, 2003
• Sigma Theta Tau Graduate Award Recipient, 2003
• Employee of the Year Nominee, 2003, Athens Regional Medical Center
• Excellence in Nursing Award, Medical College of Georgia Emergency Medicine Residents, 1999
• Sigma Theta Tau Nursing Honor Society (1996 - present)

::  Crystal Sims MS APRN-BC

Education

• Master of Science, Family Nurse Practitioner, 2005
• North Georgia College & State University, Dahlonega, Georgia
  Research Project: The Lived Experience of Adolescents Living With ADHD
• Bachelor of Science in Nursing, 2003
  Medical College of Georgia, Athens, Georgia
• Associate Degree in Nursing, 1999
  Athens Technical College, Athens, Georgia

• Collaborated with fellow graduate NP students to provide educational programs at a women's shelter
• North Georgia College & State University Honor Society for Nursing

::  Ginny Hunsinger, Office Manager

Education

• 1994 University of North Carolina Pembroke, Pembroke, NC - Course of Study, History and Public Relations
• 1999 Credentialing Program, Academy for Healthcare Management - Awarded designation of Professional, Academy for Healthcare Management (FAHM)
• 2002 American Academy of Professional Coders (AAPC) - Medical Coder Certification

• 2000 - Present Administrator - Neurological Associates, P.C.
• 1999 - 2000 Supervisor of Marketing/Office Manager - Blue Cross Blue Shield Northeast Georgia Region
• 1998 - 1999 Executive Assistant - Blue Cross Blue Shield
  Northeast Georgia Region
• 1995 - 1997 Office Manager - NetWorks Enterprises
• 1993 - 1995 Assistant to Public Relations Director - Pro-Image Associates